Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA
The IMID Forum5 Kesä 2025

Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, he discusses two papers: risk of MACE in patients with RA treated with JAKis compared to bDMARDs from the “JAK-pot” study, and the efficacy and safety of zimlovisertib, ritlecitinib and tofacitinib, alone and in combination, in patients with RA and an inadequate response to MTX.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(420)

Discussing RA: Impact of BMI on response to JAK inhibitors in RA

Discussing RA: Impact of BMI on response to JAK inhibitors in RA

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review paper by Bechman et al. where he highlights the i...

8 Loka 7min

Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials

Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials

Join Dr Sofia Ramiro and Dr Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered whether men and women with axSpA respond differently to bimeki...

30 Syys 20min

Author Interview: Doctor Elise van Mulligen, September 2026

Author Interview: Doctor Elise van Mulligen, September 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor van Mulligen, from the Department of Rheumatology, Leiden University Medical Centre, as they discuss her recent paper ‘Lo...

3 Syys 21min

Discussing RA: Biologic effectiveness and treatment persistence in RA

Discussing RA: Biologic effectiveness and treatment persistence in RA

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Finckh et al. and Charles‑Schoeman et a...

27 Elo 8min

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in PsA. This month’s conversation explores rec...

20 Elo 24min

Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026

Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026

Join Professor Peter Nash from the Griffith University in Brisbane; Professor Axel Finckh, from the Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland; and Bente Glintborg, an ...

13 Elo 26min

Discussing RA: Advanced therapy outcomes in RA

Discussing RA: Advanced therapy outcomes in RA

Join Professor Iain McInnes and Doctor Philip Mease for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they examine key findings from studies b...

30 Heinä 27min

Author Interview: Professor Laura Coates, July 2026

Author Interview: Professor Laura Coates, July 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Laura Coates, Professor at the University of Oxford’s Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Scie...

22 Heinä 26min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
aamukahvilla
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
psykologia
rss-rahamania
rss-narsisti
kesken
rss-liian-kuuma-peruna
rss-luonnollinen-synnytys-podcast
rss-arkea-ja-aurinkoa-podcast-espanjasta
adhd-podi
aloita-meditaatio
rss-koira-haudattuna
rss-uskonto-on-tylsaa
ihminen-tavattavissa-tommy-hellsten-instituutti
koulu-podcast-2
rss-valo-minussa-2
rss-niinku-asia-on
rss-oispa-viinii